Dexcom Inc
DXCMNasdaqCIK 1093557HealthcareFiscal year ends Dec 31
Reports and events: 311 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001093557-26-000193 |
| 2026-09-1416:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001093557-26-000175 |
| 2026-09-1016:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001093557-26-000167 |
| 2026-07-3017:21 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001093557-26-000143 |
| 2026-07-3016:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001093557-26-000142 |
| 2026-05-2817:15 ET | 8-K | 5.07 Shareholder vote results | 0001093557-26-000105 |
| 2026-05-1519:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001093557-26-000085 |
| 2026-04-3017:20 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001093557-26-000073 |
| 2026-04-3016:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001093557-26-000072 |
| 2026-04-1516:11 ET | DEF 14A | Proxy statementPeriod 2026-05-27 | 0001093557-26-000061 |
| 2026-03-0216:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001093557-26-000038 |
| 2026-02-2616:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001093557-26-000031 |
| 2026-02-1217:20 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001093557-26-000027 |
| 2026-02-1216:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001093557-26-000025 |
| 2026-01-1207:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001093557-26-000003 |
| 2025-12-2216:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001093557-25-000291 |
| 2025-10-3017:19 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001093557-25-000280 |
| 2025-10-3016:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001093557-25-000278 |
| 2025-10-2716:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001093557-25-000264 |
| 2025-09-1619:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001093557-25-000257 |
| 2025-07-3017:19 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001093557-25-000243 |
| 2025-07-3016:02 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001093557-25-000241 |
| 2025-05-1308:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001093557-25-000159 |
| 2025-05-0916:20 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001093557-25-000134 |
| 2025-05-0916:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001093557-25-000129 |
| 2025-05-0216:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001093557-25-000117 |
| 2025-05-0117:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001093557-25-000113 |
| 2025-05-0116:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001093557-25-000111 |
| 2025-03-2709:01 ET | DEF 14A | Proxy statementPeriod 2025-05-08 | 0001093557-25-000100 |
| 2025-03-2516:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001093557-25-000088 |
| 2025-03-1008:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001093557-25-000050 |
| 2025-03-0716:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001093557-25-000047 |
| 2025-02-1817:52 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001093557-25-000036 |
| 2025-02-1316:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001093557-25-000029 |
| 2025-01-1307:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001093557-25-000004 |
| 2024-12-2316:05 ET | 8-K | 1.01 Entry into a material agreement | 0001093557-24-000197 |
| 2024-10-2417:13 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001093557-24-000180 |
| 2024-10-2416:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001093557-24-000179 |
| 2024-07-2517:18 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001093557-24-000144 |
| 2024-07-2516:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001093557-24-000143 |
| 2024-05-2416:12 ET | 8-K | 5.07 Shareholder vote results | 0001093557-24-000101 |
| 2024-04-2517:17 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001093557-24-000079 |
| 2024-04-2516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001093557-24-000078 |
| 2024-04-2216:32 ET | DEF 14A | Proxy statementPeriod 2024-05-22 | 0001093557-24-000070 |
| 2024-02-1516:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001093557-24-000024 |
| 2024-02-0817:14 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001093557-24-000021 |
| 2024-02-0816:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001093557-24-000020 |
| 2024-01-0808:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001093557-24-000003 |
| 2023-11-0216:19 ET | 8-K | 8.01 Other events | 0001093557-23-000222 |
| 2023-10-2617:14 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001093557-23-000220 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:23 ET. Listed shows no prices and gives no investment advice.